Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
22044
Beskrivning
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00327652
Länk
https://clinicaltrials.gov/show/NCT00327652
Nyckelord
Versioner (3)
- 2017-05-16 2017-05-16 -
- 2017-05-16 2017-05-16 -
- 2021-09-20 2021-09-20 -
Uppladdad den
16 maj 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Neoplasm Metastasis NCT00327652
Eligibility Neoplasm Metastasis NCT00327652
- StudyEvent: Eligibility
Similar models
Eligibility Neoplasm Metastasis NCT00327652
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Carcinoma | Standard therapy refractory | Standard therapy Unavailable | Liver carcinoma
Item
1. documented carcinoma refractory to standard treatment (or for whom no standard treatment is available). hepatocellular carcinoma (hcc) is not allowed.
boolean
C0007097 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0686905 (UMLS CUI [3,2])
C2239176 (UMLS CUI [4])
C2936643 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0686905 (UMLS CUI [3,2])
C2239176 (UMLS CUI [4])
Secondary malignant neoplasm of liver
Item
2. hepatic metastases
boolean
C0494165 (UMLS CUI [1])
ECOG performance status | Karnofsky Performance Status
Item
3. ecog performance status of 0 or 1, or karnofsky performance status (kps) of 80% to 100%.
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
C0206065 (UMLS CUI [2])
Organ function
Item
4. adequate organ function as defined by clinical hematology and chemistry assays.
boolean
C0678852 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria (abbreviated):
boolean
C0680251 (UMLS CUI [1])
CNS metastases
Item
1. known central nervous system metastases.
boolean
C0686377 (UMLS CUI [1])
Allergy to sulfonamides | BETA LACTAM ALLERGY
Item
2. history of allergic reactions attributed to sulfa or beta-lactam antibiotics.
boolean
C0038757 (UMLS CUI [1])
C0741476 (UMLS CUI [2])
C0741476 (UMLS CUI [2])
Condition cardiac | Endocarditis High risk | Endocarditis Risk Moderate
Item
3. cardiac conditions associated with high- or moderate-risk of endocarditis.
boolean
C0348080 (UMLS CUI [1,1])
C0018787 (UMLS CUI [1,2])
C0014118 (UMLS CUI [2,1])
C0332167 (UMLS CUI [2,2])
C0014118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205081 (UMLS CUI [3,3])
C0018787 (UMLS CUI [1,2])
C0014118 (UMLS CUI [2,1])
C0332167 (UMLS CUI [2,2])
C0014118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205081 (UMLS CUI [3,3])
Hepatic artery catheter | Liver Cirrhosis | Ascites
Item
4. intra-arterial hepatic catheter, hepatic cirrhosis, or clinically relevant ascites.
boolean
C1321092 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0003962 (UMLS CUI [3])
C0023890 (UMLS CUI [2])
C0003962 (UMLS CUI [3])
Artificial joint | Joint Prosthesis | Artificial Implants | Artificial structure
Item
5. artificial (prosthetic) joint or other artificial implant or devices that cannot easily be removed.
boolean
C0481488 (UMLS CUI [1])
C0022414 (UMLS CUI [2])
C0021113 (UMLS CUI [3])
C0336559 (UMLS CUI [4])
C0022414 (UMLS CUI [2])
C0021113 (UMLS CUI [3])
C0336559 (UMLS CUI [4])
Blood Coagulation Disorders | Thromboembolism
Item
6. known coagulation disorder or recent thromboembolic event.
boolean
C0005779 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
C0040038 (UMLS CUI [2])
Immunosuppressive Agents | Chemotherapy | Therapeutic radiology procedure | CRS-100 | Bone Marrow Transplantation | Stem cell transplant | Organ Major Allograft | Autoimmune Disease
Item
7. use of immunosuppressive agent, chemotherapy, or radiation therapy within 28 days prior to crs-100; bone marrow or stem cell transplant or a major organ allograft; autoimmune disease.
boolean
C0021081 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C1831855 (UMLS CUI [4])
C0005961 (UMLS CUI [5])
C1504389 (UMLS CUI [6])
C0178784 (UMLS CUI [7,1])
C0205164 (UMLS CUI [7,2])
C0040739 (UMLS CUI [7,3])
C0004364 (UMLS CUI [8])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C1831855 (UMLS CUI [4])
C0005961 (UMLS CUI [5])
C1504389 (UMLS CUI [6])
C0178784 (UMLS CUI [7,1])
C0205164 (UMLS CUI [7,2])
C0040739 (UMLS CUI [7,3])
C0004364 (UMLS CUI [8])
Cholelithiasis | Nephrolithiasis
Item
8. current history of gallstones or kidney stones.
boolean
C0008350 (UMLS CUI [1])
C0392525 (UMLS CUI [2])
C0392525 (UMLS CUI [2])
HIV Infection | Human T-cell lymphotropic virus 1 infection | Hepatitis C | Hepatitis B
Item
9. infection with hiv, human t-lymphotropic virus type 1 (htlv-1), hepatitis c virus (hcv), or hepatitis b virus (hbv).
boolean
C0019693 (UMLS CUI [1])
C1512326 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019163 (UMLS CUI [4])
C1512326 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019163 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
10. pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])